Case Study: ZBiotics achieves 100% accurate engineered probiotic development with Twist Bioscience

A Twist Bioscience Case Study

Preview of the ZBiotics Case Study

ZBiotics launches the world’s first engineered probiotic with Twist Bioscience

ZBiotics, a synthetic biology startup, aimed to create the world's first engineered probiotic to help break down acetaldehyde, a toxic byproduct of alcohol metabolism in the gut. Their challenge was to design a safe, effective probiotic with a perfectly accurate synthetic gene, requiring absolute precision in DNA synthesis. They partnered with Twist Bioscience for this critical component.

Twist Bioscience provided 100% accurate synthetic DNA for the acetaldehyde dehydrogenase gene, which was verified by next-generation sequencing. This enabled ZBiotics to engineer a safe, non-colonizing *Bacillus subtilis* strain that successfully broke down acetaldehyde. The result was ZBiotics, a successfully marketed product with compelling customer testimonials, establishing it as the first genetically modified probiotic to hit the market.


View this case study…

ZBiotics

Dr. Zack Abbott

CEO and founder


Twist Bioscience

13 Case Studies